GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
2022-07-29 $22.99 $23.68 $22.32 $23.62 786 976
2022-07-28 $24.11 $24.20 $23.13 $23.23 871 703
2022-07-27 $23.21 $24.14 $22.79 $23.95 557 540
2022-07-26 $22.77 $23.30 $22.26 $22.92 729 067
2022-07-25 $22.21 $22.91 $21.87 $22.87 508 013
2022-07-22 $23.61 $23.84 $22.14 $22.17 1 168 240
2022-07-21 $23.93 $24.20 $23.05 $23.50 638 759
2022-07-20 $23.49 $24.64 $23.49 $24.04 1 064 439
2022-07-19 $22.77 $23.79 $22.77 $23.54 768 022
2022-07-18 $23.06 $23.44 $22.09 $22.35 619 124
2022-07-15 $23.13 $23.39 $22.60 $22.94 753 307
2022-07-14 $22.97 $23.14 $22.40 $22.68 744 354
2022-07-13 $22.19 $23.30 $22.05 $23.02 1 198 871
2022-07-12 $22.61 $23.09 $21.74 $22.64 1 082 733
2022-07-11 $23.81 $24.32 $22.53 $22.67 864 406
2022-07-08 $24.94 $25.14 $23.65 $24.05 939 239
2022-07-07 $25.26 $25.92 $24.76 $25.11 1 203 778
2022-07-06 $26.74 $27.02 $24.72 $25.33 972 311
2022-07-05 $26.50 $26.97 $25.12 $26.85 1 582 680
2022-07-01 $24.85 $27.02 $24.61 $26.76 1 001 502
2022-06-30 $24.95 $25.18 $24.14 $24.78 969 094
2022-06-29 $25.02 $25.51 $24.47 $25.49 660 774
2022-06-28 $25.94 $26.21 $24.64 $25.08 739 621
2022-06-27 $26.33 $26.61 $25.00 $26.00 1 291 994
2022-06-24 $27.77 $27.79 $25.13 $26.15 2 344 665
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT